Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

ExpreS2ion Biotech (EXPRS2)

Latest price

SEK1.34

−0.06 (−3.96)
As at 05/08/2026
Market capitalisation
SEK32m
View equity

Genedrive (GDR)

Latest price

GBP0.01

0.00 (0.00)
As at 05/08/2026
Market capitalisation
GBP19m

Herantis Pharma (HRTIS)

Latest price

EUR1.51

−0.04 (−2.33)
As at 05/08/2026
Market capitalisation
EUR41m
View equity

Spotlight — flash

Healthcare

Herantis Pharma — FDA feedback clears HER-096 Phase IIa path

edison tv

Healthcare

Herantis Pharma – equity proposition

Spotlight — flash

Healthcare

Herantis Pharma — Biomarker partner to support planned Phase II

Hyloris Pharmaceuticals (HYL)

Latest price

EUR4.70

0.19 (4.21)
As at 05/08/2026
Market capitalisation
EUR132m

Immix Biopharma (IMMX)

Latest price

USD9.54

0.21 (2.25)
As at 05/08/2026
Market capitalisation
USD520m
View equity

Kooth (KOO)

Latest price

GBP1.51

2.50 (1.69)
As at 05/08/2026
Market capitalisation
GBP55m
View equity

LTR Pharma (LTP)

Latest price

AUD0.46

−0.03 (−6.19)
As at 05/08/2026
Market capitalisation
AUD89m
View equity

Mendus (IMMU)

Latest price

SEK6.71

−0.16 (−2.33)
As at 05/08/2026
Market capitalisation
SEK435m
View equity

Flash

Healthcare

Mendus — Collaboration supports VITAL-TFR2 plans

Flash

Healthcare

Mendus — VITAL-CML remains on track for H226 readout

edison tv

Healthcare

Mendus – equity proposition

MindMaze Therapeutics (MMTX)

Latest price

CHF0.24

0.02 (9.77)
As at 05/08/2026
Market capitalisation
CHF43m
View equity

Newron Pharmaceuticals (NWRN)

Latest price

CHF12.26

0.44 (3.72)
As at 05/08/2026
Market capitalisation
CHF256m
View equity

Ocugen (OCGN)

Latest price

USD1.28

−0.03 (−2.29)
As at 05/08/2026
Market capitalisation
USD435m
View equity

Oncopeptides (ONCO)

Latest price

SEK1.60

0.00 (−0.13)
As at 05/08/2026
Market capitalisation
SEK610m
View equity

OpGen (OPGN)

Latest price

USD5.00

−1.80 (−26.47)
As at 05/08/2026
Market capitalisation
USD62m
View equity
Laboratory Opgen

Update

Healthcare

OpGen — Cash concerns dampen active Q2

Laboratory Opgen

Flash note

Healthcare

OpGen — FIND collaboration advances to development

Flash note

Healthcare

OpGen — Feasibility milestone from FIND collaboration

Oryzon Genomics (ORY)

Latest price

EUR2.93

−0.02 (−0.81)
As at 05/08/2026
Market capitalisation
EUR248m
View equity

OSE Immunotherapeutics (OSE)

Latest price

EUR3.26

0.05 (1.56)
As at 05/08/2026
Market capitalisation
EUR77m
View equity

Pentixapharm Holding (PTP)

Latest price

EUR1.93

0.05 (2.39)
As at 05/08/2026
Market capitalisation
EUR48m
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.